{'fraction_non_alphanumeric': 0.018808777429467086, 'fraction_numerical': 0.0, 'mean_word_length': 4.862385321100917, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Antagonism of indinavir and saquinavir confirmed.


 Double protease inhibitor combinations may be effective in some AIDS patients who do not respond to or who are intolerant of routines with a single protease inhibitor, according to an in vitro study at Harvard. The most commonly used combination was ritonavir (Norvir) and saquinavir. The findings showed anti-HIV effects on strains never exposed to treatment, as well as HIV strains that were resistant to AZT and nucleoside analogs. Little patient data is available, but what is available seems to contradict the laboratory tests. Further research is needed to resolve the conflict.
